Table 4.
Prescription of drugs for obstructive airway diseases stratified by diagnoses of asthma and chronic obstructive airway disease in a cohort of people with intellectual disabilities (ID) and a referent sample from the general population (gPop).
| Drugs | gPop | ID | ||||||
|---|---|---|---|---|---|---|---|---|
| No Diagnosis (n = 7538) |
Asthma Only (n = 179, 45% a) |
COPD Only (n = 165, 41% a) |
Asthma and COPD (n = 54, 14% a) |
No Diagnosis (n = 7660) |
Asthma Only (n = 89, 32% a) |
COPD Only (n = 151, 55% a) |
Asthma and COPD (n = 36, 13% a) |
|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| At least one R03 | 1122 (15) | 156 (87) | 160 (97) | 54 (100) | 698 (9) | 73 (82) | 142 (94) | 35 (97) |
| R03A: Adrenergics, inhalants | 932 (12) | 135 (75) | 157 (95) | 54 (100) | 490 (6) | 65 (73) | 129 (85) | 33 (92) |
| R03BA: Glucocorticoids | 495 (7) | 57 (32) | 110 (67) | 34 (63) | 208 (3) | 25 (28) | 88 (58) | 22 (61) |
| R03BB: Anticholinergics | 141 (2) | 112 (63) | 20 (12) | 39 (72) | 73 (1) | 52 (58) | 18 (12) | 16 (44) |
| R03C: Adrenergics for systemic use | 21 (0) | 1 (1) | 5 (3) | 0 (0) | 194 (3) | 11 (12) | 52 (34) | 12 (33) |
| R03D: Other systemic drugs | 45 (1) | 11 (6) | 26 (16) | 13 (24) | 69 (1) | 10 (11) | 38 (25) | 5 (14) |
a: Percentage based on the number of people with at least one diagnosis.